Literature DB >> 34336879

Scoring System to Evaluate the Performance of ICU Ventilators in the Pandemic of COVID-19: A Lung Model Study.

Xingshuo Hu1, Fei Xie1, Kaifei Wang1, Hongjun Gu1, Guoxin Mo1, Ruoxuan Wen1, Ying Zhao1, Qingyun Yang1, Knut Möller2, Zhanqi Zhao2,3, Lixin Xie1.   

Abstract

Ventilators in the intensive care units (ICU) are life-support devices that help physicians to gain additional time to cure the patients. The aim of the study was to establish a scoring system to evaluate the ventilator performance in the context of COVID-19. The scoring system was established by weighting the ventilator performance on five different aspects: the stability of pressurization, response to leaks alteration, performance of reaction, volume delivery, and accuracy in oxygen delivery. The weighting factors were determined with analytic hierarchy process (AHP). Survey was sent out to 66 clinical and mechanical experts. The scoring system was built based on 54 valid replies. A total of 12 commercially available ICU ventilators providing non-invasive ventilation were evaluated using the novel scoring system. A total of eight ICU ventilators with non-invasive ventilation mode and four dedicated non-invasive ventilators were tested according to the scoring system. Four COVID-19 phenotypes were simulated using the ASL5000 lung simulator, namely (1) increased airway resistance (IR) (10 cm H2O/L/s), (2) low compliance (LC) (compliance of 20 ml/cmH2O), (3) low compliance plus increased respiratory effort (LCIE) (respiratory rate of 40 and inspiratory effort of 10 cmH2O), (4) high compliance (HC) (compliance of 50 ml/cmH2O). All of the ventilators were set to three combinations of pressure support and positive end-expiratory pressure levels. The data were collected at baseline and at three customized leak levels. Significant inaccuracies and variations in performance between different non-invasive ventilators were observed, especially in the aspect of leaks alteration, oxygen and volume delivery. Some ventilators have stable performance in different simulated phenotypes whereas the others have over 10% scoring differences. It is feasible to use the proposed scoring system to evaluate the ventilator performance. In the COVID-19 pandemic, clinicians should be aware of possible strengths and weaknesses of ventilators.
Copyright © 2021 Hu, Xie, Wang, Gu, Mo, Wen, Zhao, Yang, Möller, Zhao and Xie.

Entities:  

Keywords:  accuracy in volume delivery; analytic hierarchy process; leakage correction; performance of triggering; scoring system; stability of pressurization; ventilator performance

Year:  2021        PMID: 34336879      PMCID: PMC8316635          DOI: 10.3389/fmed.2021.663608

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


Introduction

Ventilator in the intensive care units (ICU) is life-support device that helps physicians gaining additional time to cure the patients. Several previous studies have compared the performance of different ventilators regarding triggering (1), system leaks (2, 3), and accuracy in volume and pressure delivery (4). The performance varied from device to device, and depended on the testing items. One device might be accurate in volume but not in pressure delivery. A complex scoring system to evaluate the overall performance of ventilator regarding various aspects is missing. The outbreak of the novel coronavirus disease 2019 (COVID-19) has spread rapidly around the world (5). About 19% of patients in China developed hypoxic respiratory failure and required certain level of ventilation support (6).The situation in other countries is similar. Patients with COVID-19 show various phenotypes that may require different respiratory treatments, characterized as low compliance (LC) due to lung collapse or high airway resistance due to inflammation and mucus (7, 8). The performance of ventilator could be various for different phenotypes, which was not well-studied. Since the number of infected patients is large and still increases dramatically, a large number of ventilators required to support patients' respiratory system (9). New companies are recruited to build ventilators, which might have no experience on manufacturing ventilators or even medical devices prior to the pandemic. A well-designed scoring system may be helpful for the evaluation and improvement of the ventilators. The aim of the study was to establish a scoring system to evaluate the ventilator overall performance, as well as different aspects. Based on the proposed scoring system, ICU most commonly used ventilators in China were compared in order to demonstrate the feasibility of the novel scoring system. We hypothesized that the performances of the ventilators evident.

Materials and Methods

The scoring system was established using the analytic hierarchy process (AHP) (10). The AHP hierarchy consisted of five criteria regarding the ventilator performance, which were selected based on our experiences and previous studies (2–4).

The Stability of Pressurization

The stability of pressurization refers to the control precision of pressurization during ventilation. It contains three alternatives: (1) maximum pressure drop, the absolute difference between expiratory positive airway pressure (EPAP) and the lowest pressure during inspiration; (2) inspiratory positive airway pressure (IPAP) error, the absolute difference between the actual pressure and the set IPAP during inspiration; (3) EPAP error, the absolute difference between the actual pressure and the set EPAP during expiration.

Response to Leaks Alteration

Leak correction represents the ability of the ventilator to adapt to the changes of a systematic leak. It has two alternatives: time needed from the moment a leak was increased or decreased until the tidal volume was within 2 standard deviations of the mean tidal volume for each leak level. They were denoted as time to settle (increase) and time to settle (decrease).

Performance of Reaction

To evaluate the performance of reaction, the following alternatives are considered: (1) Exp T90, the time to accomplish 90% of the drop from peak pressure to EPAP; (2) Insp T90, the time to accomplish 90% of the rise to IPAP; (3) trigger time, point in time at which airway pressure has returned to baseline after downward deflection (start of inspiration effort).

Volume Delivery

Volume delivery assesses the gas output of a ventilator, includes (1) peak flow rising ratio during inhalation (peak flow divided by Insp T90) and (2) tidal volume.

Accuracy in Oxygen Delivery

The accuracy in oxygen delivery refers to the difference between the preset oxygen concentration and the actual one delivered. The AHP evaluation criteria are illustrated in Figure 1. The relative weights of the nodes in the hierarchy were determined using a survey (https://www.wjx.cn/jq/102986570.aspx.) The participants consisted of senior intensivists (chief physician) and engineers of ventilator manufacturers (>5 years as senior engineer). The participants evaluated the hierarchy through a series of pairwise comparisons that derive numerical scales of measurement for the nodes (i.e., 0 or 1). The criteria are pairwise compared for importance. The alternatives are pairwise compared against each of the criteria for preference. The priorities are derived correspondingly for each node as described in the previous study (11).
Figure 1

(Top) Illustration of the analytic hierarchy process hierarchy. (Bottom) explanation of the evaluated parameters. (Top) EPAP, expiratory positive airway pressure; IPAP, inspiratory positive airway pressure; Exp T90, the time to accomplish 90% of the drop from peak pressure to EPAP; Insp T90, the time to accomplish 90% of the rise to IPAP. For detailed explanation of the nodes, please refer to the text. (Bottom) A, Tidal volume: The volume of gas the user inhales; B, Flow efficiency: Peak flow divided by the length of Insp T90; C, Maximum pressure drop: Deflection of airway pressure from baseline (EPAP) to Pmin; D, Time to trigger: Point in time at which airway pressure has returned to baseline (EPAP) after a downward deflection; E, Insp T90: The time to accomplish 90% of the rise to IPAP; F, Exp T90: The time to accomplish 90% of the drop from peak pressure to EPAP; G, IPAP error: The difference between Ppeak and the set IPAP; H, EPAP error: The difference between the positive end-expiratory pressure and the set EPAP.

(Top) Illustration of the analytic hierarchy process hierarchy. (Bottom) explanation of the evaluated parameters. (Top) EPAP, expiratory positive airway pressure; IPAP, inspiratory positive airway pressure; Exp T90, the time to accomplish 90% of the drop from peak pressure to EPAP; Insp T90, the time to accomplish 90% of the rise to IPAP. For detailed explanation of the nodes, please refer to the text. (Bottom) A, Tidal volume: The volume of gas the user inhales; B, Flow efficiency: Peak flow divided by the length of Insp T90; C, Maximum pressure drop: Deflection of airway pressure from baseline (EPAP) to Pmin; D, Time to trigger: Point in time at which airway pressure has returned to baseline (EPAP) after a downward deflection; E, Insp T90: The time to accomplish 90% of the rise to IPAP; F, Exp T90: The time to accomplish 90% of the drop from peak pressure to EPAP; G, IPAP error: The difference between Ppeak and the set IPAP; H, EPAP error: The difference between the positive end-expiratory pressure and the set EPAP. Further, eight ICU ventilators with non-invasive ventilation mode and four dedicated non-invasive ventilators were tested according to the scoring system. The features of the tested ventilators are summarized in Table 1. The setting of the ventilators was the same: spontaneous timed mode, 10/min, Inspiratory rise time, when adjustable, was set to the fastest value that did not cause an initial pressure overshoot that would shut down the lung model, and triggering was set at the most sensitive value that did not cause auto-triggering. Four COVID-19 phenotypes were simulated using the ASL5000 lung simulator (IngMar Medical, PA, USA), namely (1) LC, low compliance (compliance of 20 ml/cmH2O), (2) IR, increased airway resistance (10 cm H2O/L/s), (3) LCIE, low compliance plus increased respiratory effort (respiratory rate of 40 and inspiratory effort of 10 cmH2O), and (4) HC, high compliance (compliance of 50 ml/cmH2O). All of the ventilators were set to three combinations of IPAP and EPAP levels (10 and 4 cmH2O, 20 and 8 cmH2O, 30 and 12 cmH2O, IPAP and EPAP, respectively). The data were collected at baseline and at three customized leak levels for dedicated non-invasive ventilators (50, 70, and 90 L/min) and for ICU ventilators using non-invasive mode (14, 19 and 25 L/min).
Table 1

Summary of ventilators examined in the study.

VentilatorConnection type (circuit)ManufacturerLeakage compensation (L/min)Trigger typeCycling type
BiPAP V60SinglePhilips, NL60Auto-flowAuto-flow
Bellavista 1000SingleImtmedical, CH120Auto-pressure, flowAuto-pressure, flow, volume
ST-30KSingleMicomme, CN120Auto-flowAuto-flow
carinaSingleDraeger Medical, DE50Manual-pressure, flowManual-pressure, flow
VG55SingleAeonMed, CN200Manual-flowManual-flow
GASingleResMedandCurative, CN120Manual-pressure, flowManual-flow
VG70DoubleAeonMed, CN60Manual-pressure, flowManual-pressure, flow
SV800DoubleMindray, CN65Manual-pressure, flowManual-pressure, flow
Servo-IDoubleGetingeGroup, SE65Manual-pressure, flowManual-flow
R860DoubleGE Medical, US100Manual-pressure, flowManual-flow
VELADoubleCareFusion, US60Manual-flowManual-pressure, flow, volume
V200DoublePhilips, NL60Auto-flowAuto-flow
Summary of ventilators examined in the study.

Data Collection

Test hardware and its connection are illustrated in Figure 2. The test process consists of four steps: (1) Start the test after setting the lung simulator according to the parameters described previously, and adjustment of the control valve reaching the specified air leakage of the ventilator. (2) Keep the opening of the control valve and restart the lung simulator for testing for 1 min. (3) Repeat the above two steps until three different air leakages have been tested. (4) Dynamic air leakage test was carried out through a control valve with three gears. Data acquisition was done at 512 Hz and stored in a desktop computer.
Figure 2

Illustration of test hardware and connection.

Illustration of test hardware and connection.

Statistical Analysis

Offline analysis on a breath by breath basis was done by the ASL5000 Lab view software (National Instruments, Austin, TX, USA). All breaths were visually inspected and five breaths during equilibrium state were selected for analysis. Outliers were defined as 1.5 times interquartile range. The outliers were eliminated from further analysis. The ranges of the targeted parameters are listed in Table 2. When a ventilator performance was outside of the range, it scored 1 or 0 for better or worse performance, respectively. Mean values of the score were calculated when multiple levels of testing were performed. The overall performance is weight sum of all nodes.
Table 2

Ranges of the targeted parameters.

ParametersscoreLCIRLCIEHC
Preset pressure (cmH2O)
4–108–2012–304–108–2012–304–108–2012–304–108–2012–30
Tidal volume (ml)0120200250190350480180184229300400450
12704005404907801,0254165615726009001,200
Peak flow rising ratio (l/s2)00000
1106153
Trigger time (ms)0400600400600
160906060
Maximum pressure drop (cmH2O)03.552.5572.55
10000
Exp T90 (ms)06001,0006001,400
1100150100100
Insp T90(ms)09001,2009001,400
1100150100300
IPAP error (cmH2O)0±5±10±15±5±10±15±5±10±15±5±10±15
1000000000000
EPAP error (cmH2O)0±2±4±62±4±62±4±62±4±6
1000000000000
Time to settle (increase) (s)020
10
Time to settle (decrease) (s)012
10
Oxygen delivery %setting60%
0±10
10
setting100%
080
198

IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance.

Ranges of the targeted parameters. IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance.

Results

The survey was sent out to 66 clinical and engineering experts. The weighting factors were defined based on 54 valid replies (16 from senior intensivist and 38 from engineers). The final weights of the nodes are summarized in Table 3. The nodes of the criterion “pressurization” had similar weights. The experts considered time to settle (increase) and tidal volume much more important than the time to settle (decrease) and peak flow rising ratio, respectively. Trigger time was the most important node in the criterion “reaction”.
Table 3

The final weights of nodes of the scoring system.

First level criteriaSecond level criteria
The stability of pressurization0.223Maximum pressure drop0.337
EPAP error0.278
IPAP error0.385
Response to leaks alteration0.229Time to settle (increase)0.622
Time to settle (decrease)0.378
Volume delivery0.160Peak flow rising ratio during inhalation0.385
Tidal volume0.615
Performance of reaction0.242Insp T900.341
Exp T900.160
Trigger time0.498
Accuracy in oxygen delivery0.146
The final weights of nodes of the scoring system. Overall performances of the ventilators under four simulated COVID-19 phenotypes were summarized in Figure 3. V60 and Servo-I have the best overall performance among the ventilators tested (for single and double circuits). Some ventilators have stable performance in different simulated phenotypes whereas the others have over 10% scoring differences (e.g., 30 K and V200). Nevertheless, the overall performances among the ventilators for double circuits were similar. The performances of the ventilators in five criteria were illustrated using radar charts (Figure 4). Significant inaccuracies and variations in performance among different ventilators were observed, especially in the aspect of response to leaks alteration, oxygen, and volume delivery. For example, Servo-I had excellent performance in response to leaks alteration in all simulated phenotypes, however, its performance in volume delivery was much weaker. The accuracy in oxygen delivery for VG70 strongly depended on the simulated phenotypes.
Figure 3

Overall performances of the ventilators under three simulated COVID-19 phenotypes. IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance. (A) non-invasive ventilators with single-circuit connection. (B) ICU ventilators with non-invasive ventilation mode and double-circuit connection.

Figure 4

Radar charts summarizing the main criteria of the performance evaluation. Data are expressed as the score calculated based on the proposed scoring system. Scores for three simulated COVID-19 phenotypes are superimposed on the same chart (IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance). The following five characteristics are summarized for each ventilator (clock-wise): the stability of pressurization (pressure), response to leaks alteration (leak), volume delivery (volume), performance of reaction (reaction), and accuracy in oxygen delivery (oxygen). (A) Non-invasive ventilators with single-circuit connection. (B) ICU ventilators with non-invasive ventilation mode and double-circuit connection.

Overall performances of the ventilators under three simulated COVID-19 phenotypes. IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance. (A) non-invasive ventilators with single-circuit connection. (B) ICU ventilators with non-invasive ventilation mode and double-circuit connection. Radar charts summarizing the main criteria of the performance evaluation. Data are expressed as the score calculated based on the proposed scoring system. Scores for three simulated COVID-19 phenotypes are superimposed on the same chart (IR, increased airway resistance; LC, low compliance; LCIE, low compliance plus increased respiratory effort; HC, high compliance). The following five characteristics are summarized for each ventilator (clock-wise): the stability of pressurization (pressure), response to leaks alteration (leak), volume delivery (volume), performance of reaction (reaction), and accuracy in oxygen delivery (oxygen). (A) Non-invasive ventilators with single-circuit connection. (B) ICU ventilators with non-invasive ventilation mode and double-circuit connection.

Discussion

In the present study, we demonstrated the process of establishing a scoring system to evaluate the overall performance of ventilators. Further, with help of the proposed scoring system, 12 ventilators were evaluated. It was found that the performance of ventilators depended on targeted lung models and varied significantly among different investigated criteria. COVID-19 may affect the respiratory system in various ways. In patients with respiratory failure, the oxygen level may drop to a low level that meets the definition of acute respiratory distress syndrome. However, the respiratory system compliance may still be normal (7). The compliance may decrease during disease progression, which might be caused by inappropriate settings of ventilator (12). If the performance of the ventilator is unacceptable with large discrepancy between set values and actual ones, ventilator-induced lung injury might occur even the ventilator settings were optimized. In combination with other existing lung diseases in the patients, such as chronic obstructive lung disease, more frequent monitoring and modified respiratory therapy are required in ICU (13). In the present study, we simulated four phenotypes of COVID-19, with possibly increase of airway resistance (IR), decrease of compliance (LC), increase of inspiratory effort (LCIE), or HC. The ventilators evaluated in the study showed different performances under different lung models. In clinical practice, if more than one type of ventilator was available, the one that best fits the underlying disease should be selected. If only limited types of ventilators are at disposal, intensivist, or respiratory therapist should be aware of the pitfalls of the ventilators during application. Taking the ventilator Bellavista for example, when it is applied on COVID-19 patient with LC, and the measured leakage is ~60 L/min, we suggest that the ventilator should be adjusted according to the findings of the present study (Figure 5). In particular, response to leaks alteration and volume delivery of this ventilator scored low. Leakage reduction and IPAP increase should be considered in this scenario.
Figure 5

Example on how the findings of the current study could be used in clinical practice. The ventilator Bellavista was used in a patient with lung status similar to the low compliance (LC) model we simulated in the current study. Leakage measured was ~50–70 L/min under the presented ventilator settings. Based on the quality levels we found, the ventilator settings should be adjusted accordingly.

Example on how the findings of the current study could be used in clinical practice. The ventilator Bellavista was used in a patient with lung status similar to the low compliance (LC) model we simulated in the current study. Leakage measured was ~50–70 L/min under the presented ventilator settings. Based on the quality levels we found, the ventilator settings should be adjusted accordingly. The current pandemic has created medical resource scarcities, especially in regions where ventilators and trained personnel are already in short supply. Many new attempts of ventilator manufacturing were presented, including some low cost ventilator (14), and shared ventilator setup for multi-patient simultaneous use (15). The scoring system established in the present study should be able to help evaluating the performance of ventilators in a standard manner. Next generation of ventilator is toward physiological closed-loop systems (16). Decision making would be still in the hands of physicians but with the extensive physiological monitoring in current clinical environment, a physiological parameter could be accurately fed back to the controller and solve the high-stress environments as COVID-19 pandemic with a shrinking workforce (17). To develop the correct feedback loop, a full understanding of the ventilator performance is required. The current study might be a step toward the physiological closed-loop system. Besides, the proposed scoring system and the models simulated by ASL5000 may help the medical students to further understand the interaction between patients and ventilator in addition to mannequin-based and computer screen-based simulation (18). The following limitations are acknowledged. (1) The five criteria of the AHP hierarchy (and the corresponding alternatives) were predefined. Only these aspects of ventilator performance were evaluated and considered in the scoring system. Some importance aspects could have been missed when we designed this scoring system for non-invasive ventilation. For invasive ventilation mode, other parameters should be considered as well. Nevertheless, the knowledge and procedure of building the scoring system can be easily transferred. (2) The definition of the parameter value ranges in Table 2 might have influence on the overall score of particular ventilator. But if the same ranges are used for all comparison, the scores of the ventilators are comparable. (3) This was a lung model study with limited number of variations simulating COVID-19 patients. We demonstrated the performance of various ventilators under the preselected scenarios. The study design was not intended to validate the scoring system. In the future study, actual outcomes and influences on real subjects could be considered. Clinicians should be aware of possible strength and weakness of ventilators. Performance of other ventilators can be conducted using the scoring system developed in the present study. It is feasible to use the proposed scoring system to evaluate the ventilator performance. In the COVID-19 pandemic, clinicians should be aware of possible strength and weakness of ventilators.

Data Availability Statement

The original contributions generated for the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

Author Contributions

XH had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. XH, FX, KW, and HG had designed the study and analyzed the data, and revised the manuscript significantly. GM, RW, YZ, and QY had collected the data and revised the manuscript significantly. ZZ and LX contributed to study design and data interpretation, and drafted the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  15 in total

1.  A comparison of leak compensation in acute care ventilators during noninvasive and invasive ventilation: a lung model study.

Authors:  Jun Oto; Christopher T Chenelle; Andrew D Marchese; Robert M Kacmarek
Journal:  Respir Care       Date:  2013-05-21       Impact factor: 2.258

2.  Multifaceted bench comparative evaluation of latest intensive care unit ventilators.

Authors:  M Garnier; C Quesnel; J-P Fulgencio; M Degrain; G Carteaux; F Bonnet; T Similowski; A Demoule
Journal:  Br J Anaesth       Date:  2015-03-03       Impact factor: 9.166

3.  Simulation Training for Residents Focused on Mechanical Ventilation: A Randomized Trial Using Mannequin-Based Versus Computer-Based Simulation.

Authors:  Savino Spadaro; Dan Stieper Karbing; Alberto Fogagnolo; Riccardo Ragazzi; Francesco Mojoli; Luca Astolfi; Antonio Gioia; Elisabetta Marangoni; Stephen Edward Rees; Carlo Alberto Volta
Journal:  Simul Healthc       Date:  2017-12       Impact factor: 1.929

4.  ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.

Authors:  Francisco José Vivas Fernández; José Sánchez Segovia; Ismael Martel Bravo; Carlos García Ramos; Daniel Ruiz Castilla; José Gamero López; José Manuel Andújar Márquez
Journal:  Sensors (Basel)       Date:  2020-11-27       Impact factor: 3.576

5.  Evaluating cross contamination on a shared ventilator.

Authors:  Donald Joseph Doukas; Lorenzo Paladino; Christopher Hanuscin; Jonathan McMahon; John Quale; Isha Bhatt; Julie Eason; Mark Silverberg
Journal:  Emerg Med J       Date:  2020-12-04       Impact factor: 2.740

6.  The Italian health system and the COVID-19 challenge.

Authors:  Benedetta Armocida; Beatrice Formenti; Silvia Ussai; Francesca Palestra; Eduardo Missoni
Journal:  Lancet Public Health       Date:  2020-03-25

7.  Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.

Authors:  Yuying Liu; Jiadi Lv; Jiangning Liu; Man Li; Jing Xie; Qi Lv; Wei Deng; Nannan Zhou; Yabo Zhou; Jiangping Song; Peng Wang; Chuan Qin; Wei-Min Tong; Bo Huang
Journal:  Cell Res       Date:  2020-11-06       Impact factor: 25.617

Review 8.  Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.

Authors:  David M G Halpin; Gerard J Criner; Alberto Papi; Dave Singh; Antonio Anzueto; Fernando J Martinez; Alvar A Agusti; Claus F Vogelmeier
Journal:  Am J Respir Crit Care Med       Date:  2021-01-01       Impact factor: 21.405

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

10.  Time Course of Evolving Ventilator-Induced Lung Injury: The "Shrinking Baby Lung".

Authors:  John J Marini; Luciano Gattinoni
Journal:  Crit Care Med       Date:  2020-08       Impact factor: 9.296

View more
  1 in total

1.  High-flow nasal cannula: Evaluation of the perceptions of various performance aspects among Chinese clinical staff and establishment of a multidimensional clinical evaluation system.

Authors:  Ruoxuan Wen; Xingshuo Hu; Tengchen Wei; Kaifei Wang; Zhimei Duan; Zhanqi Zhao; Lixin Xie; Fei Xie
Journal:  Front Med (Lausanne)       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.